Cytogenetic Analysis

← Back to Index (🧬 Genetics)

Definition and Overview

Indications for Cytogenetic Testing

Clinical Category Specific Indications
Pediatric and Developmental Unexplained intellectual disability, global developmental delay, multiple congenital anomalies, dysmorphic features, ambiguous genitalia, and autism spectrum disorders.
Reproductive and Endocrine Primary amenorrhea, infertility, recurrent miscarriages, prior history of stillbirths or neonatal deaths.
Prenatal Testing Advanced maternal age, abnormal fetal ultrasound findings, unexplained fetal growth restriction, abnormal noninvasive prenatal testing (NIPT).
Oncology and Hematology Tumor surveillance (especially leukemia using bone marrow aspirates) and evaluation for chromosome instability syndromes.

Methodologies and Techniques

Conventional Karyotyping (G-Banding)

Molecular Cytogenetic Techniques

Technique Principles and Clinical Utility
Fluorescence In Situ Hybridization (FISH) Utilizes fluorochrome-labeled DNA probes on interphase or metaphase cells. Does not require cell culture. Used for rapid prenatal aneuploidy screening and confirmation of specific microdeletion/microduplication syndromes.
Chromosomal Microarray (CMA) Differentially labels patient and reference DNA, hybridizing them to a microarray grid. Detects copy number variations (CNVs). Provides up to 50-fold higher resolution than karyotyping and does not require dividing cells.
Single Nucleotide Polymorphism (SNP) Arrays A type of CMA that evaluates polymorphic variations. Highly useful for detecting uniparental disomy (UPD), regions of homozygosity (ROH), and consanguinity.

Types of Abnormalities Detected

Numerical Abnormalities

Structural Abnormalities

Advantages and Limitations

Modality Advantages Limitations
Conventional Karyotyping Direct visualization of the entire genome. Low cost. Essential for identifying balanced structural rearrangements (translocations, inversions). Low resolution (misses microdeletions <5 Mb). Requires dividing cells. Subjective interpretation. Time-consuming.
Chromosomal Microarray (CMA) High resolution (detects 10-50 kb anomalies). Does not require dividing cells. Automated quantitative interpretation. Higher diagnostic yield (15-20%). Cannot detect balanced chromosomal rearrangements. Cannot detect point mutations. Limited utility in detecting low-level mosaicism (<20-30%).

Current Guidelines and Clinical Integration